Showing results (61-70 of 146) with videos related to
Sort By:
Pageof 15
Drug Delivery|April 23, 2025
PEGylation technology: addressing concerns, moving forwardDmitri Simberg, Yechezkel Barenholz, Steve R Roffler, et al.Journal of Pharmaceutical Sciences|April 28, 2011
DNA hydrodynamic degradation controlled by Kolomogorov length scales in pipe flowCorinne S Lengsfeld, Leslie Munson, Yvonne K Lentz, et al.Journal of Pharmaceutical Sciences|October 14, 2014
Long-term storage of lyophilized liposomal formulationsNicole M Payton, Michael F Wempe, Yemin Xu, et al.Biochimica Et Biophysica Acta|August 5, 2003
The use of fluorescence resonance energy transfer to monitor dynamic changes of lipid-DNA interactions during lipoplex formationYe Zhang, William Garzon-Rodriguez, Mark C Manning, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 28, 2024
Exploiting a type III interferon response to improve chemotherapeutic safety and efficacyScott G Tilden, Madison H Ricco, Emily A Hemann, et al.ACS Nano|July 1, 2021
Liposomal Extravasation and Accumulation in Tumors as Studied by Fluorescence Microscopy and Imaging Depend on the Fluorescent LabelGuankui Wang, Markella Zannikou, Laren Lofchy, et al.Nature Communications|August 12, 2021
Dendrimer end-terminal motif-dependent evasion of human complement and complement activation through IgM hitchhikingLin-Ping Wu, Mario Ficker, Jørn B Christensen, et al.European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 10, 2023
Activation of the complement system by nanoparticles and strategies for complement inhibitionHajira B Haroon, Elisha Dhillon, Z Shadi Farhangrazi, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|May 25, 2023
Reducing off-target drug accumulation by exploiting a type-III interferon responseScott G Tilden, Madison H Ricco, Emily A Hemann, et al.Therapeutic Delivery|February 8, 2019
A novel method for conjugating the terminal amine of peptide ligands to cholesterol: synthesis iRGD-cholesterolMatthew G Fete, Jamie L Betker, Richard K Shoemaker, et al.Pageof 15